|
Items where Division is "Faculty of Economics > Department of Health Economics" and Year is 2014
Number of items: 4. ArticleBaji, Petra, Péntek, Márta, Czirjak, László, Szekanecz, Zoltán, Nagy, György, Gulácsi, László and Brodszky, Valentin (2014) Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison. European Journal of Health Economics . DOI 10.1007/s10198-014-0594-4 Baji, Petra, Péntek, Márta, Szántó, Sándor, Géher, Pál, Gulácsi, László and Brodszky, Valentin (2014) Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis. European Journal of Health Economics . DOI 10.1007/s10198-014-0593-5 Rencz, Fanni, Brodszky, Valentin, Varga, Péter, Gajdácsi, József, Nyirády, Péter and Gulácsi, László (2014) A prosztatarák gazdasági terhe nagy betegregiszterek alapján (The economic burden of prostate cancer. A systematic literature overview of registry-based studies). Orvosi Hetilap, 155 (13). pp. 509-520. DOI 10.1556/OH.2014.29837 BookPéntek, Márta, Baji, Petra, Brodszky, Valentin, Gulácsi, László, Balogh, Orsolya and Vártokné Hevér, Noémi (2014) Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of rheumatoid arthritis. Budapesti Corvinus Egyetem Egészségügyi Közgazdaságtan Tanszék, Budapest. . ISBN 978-963-503-575-5 |
